The worldwide biomarkers market was valued at us$ 59.1 billion in 2022 and is projected to reach us$ 193.62 Bn by 2030, growing at a CAGR of 15.99%.
This report on point-of-care diagnostics / testing (POCT) market studies various products and end-users market. POCT is considered as one of the most affordable technologies of global diagnostics market, and development in POCT technologies over period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies.
Hospital acquired infections (HAI) or diseases, also called as nosocomial infections are acquired in healthcare in-patient settings. It is estimated that in the U.S., 9.2 out of every 100 parents acquire hospital infection. Urinary tract infection and pneumonia are the most common types of HAI, followed by bloodstream infection, and surgical site infection.
This report on drug abuse testing/screening market studies various test and location types. For decades, drug of abuse test samples were transferred to laboratories with results returned days or even weeks later. More recently, point-of-collection (POC) testing became omnipresent, permitting detection of some drugs and/or their metabolites within minutes of collection.
Liquid Biopsy Market Valued At USD 1,881.9 Mn In 2015, And Expected To Reach USD 10,850.3 Mn By 2022, Expanding At A CAGR of 24.7% From 2016 - 2022
Biological Safety/Biosafety Cabinets market Was Valued At USD 151.4 Mn In 2015, And Is Expected To Reach USD 267.2 Mn By 2023, Expanding At A CAGR Of 7.4% From 2016 To 2023
Digital pathology refers to use of digital tools and solutions for automation of pathology processes and lab testing. Growing prevalence of cancer and chronic diseases, increasing demand for rapid pathological tests and automation of healthcare system are some of the major factors that facilitated the advent of digital pathology. Digital pathology conveniently improves workflow efficiency and deliver faster and accurate test results as against the conventional methods.
Global Healthcare Analytical Testing Market was estimated to be USD XX Bn in 2016 and was expected to be worth USD XX Bn by 2023. Explore the market Here!
Technical developments, growing use of filtration technologies in biotechnology and drug discovery and development, clinical laboratories has assisted the laboratory filtration market to achieve impressive growth rate. Laboratory filtration solutions are used in processes drug screening, DNA and protein separation, cell culture, and other separation and filtration processes.
The general concept of Optogenetics refers to the use of different genetically encoded probes for in vivo optical stimulation for studying neuroscience. Optogenetics is the emerging field of biotechnology that combines optical with genetic engineering to observe, analyze and control physiological functions in animal brain.
Global Medical Imaging Reagents Market was estimated to be USD XX Bn in 2017 and was expected to be worth USD XX Bn by 2027. Explore the market Here!
Growth in incidence of rectal, GI and colon cancer and flourishing trend of cancer screening through genetic testing are the prime factors allowing the growth of in vitro colorectal cancer screening market. Favorable government guidelines and regulation for increasing awareness in the general population and supporting the adoption colon cancer screening also facilitate the global demand for minimally invasive screening tests that use genetic biomarkers and DNA for risk determination.
Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in clinical as well as industrial settings.
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Rapid microbiology testing provides the qualitative, quantitative, and identification results.
Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Rapid microbiology testing provides the qualitative, quantitative, and identification results. In the next few years the demand for rapid microbiology tests in pharmaceutical industry is expected to increase significantly in the emerging economies such as China and India.
This report on plant stem market for cosmetics studies various applications of plant stem cell-based cosmetic products. Applications of plant stem cell based cosmetics products comprises skin repair, anti-inflammatory, UV protection, under eye care, skin radiance, firming, anti-cellulite, and others (hydration, lip care, and antioxidant). According to market experts, the components found in these specific plants have been demonstrated to be a significant source of phyto stem cells.
This report on plant stem market for nutrients studies various applications of plant stem cell-based nutrients products. Applications of plant stem cell based nutrition products comprises develop natural mechanism, develop stem cell physiology, cellular rejuvenation, weight loss, anti-wrinkle & others (skin hydration, antioxidant, and others).
Tissue Engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. This technique allows the organs to be grown from implantation and hence is free from immunological rejection.
This report on hematopoietic stem cells transplantation market studies various transplant types and applications. Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases.
This report on clinical laboratory services market studies various test types and service providers. Clinical laboratory comprises of anatomic pathology, clinical microbiology, and hematology.
Bioengineered skin and soft tissue substitutes are generally derived from autologous or allogeneic human tissue, xenographic tissue, synthetic materials or a composite.
Industrial Microbiology Market Was Valued At US$ 8.9 Bn In 2016, And Is Expected To Reach US$ 16.3 Bn By 2025, Expanding At A CAGR Of 6.9% From 2017 To 2025
Paper diagnostics are devices made of paper and cellulosic materials to recognize and quantify biomolecules and chemicals affecting health. There has been a rapid increase in interest for paper-based diagnostic methods in recent years.
Transplant Diagnostics Market Was Estimated At US$ 609.1 Mn In 2017 Expanding At A CAGR Of 7.4% From 2018 To 2026, To Reach US$ 1,167.4 By 2026 .
Biological safety or biological safety cabinets are widely used containment devices geared with HEPA filters to provide personnel, product and environmental protection from biohazardous material.
Single-Use Bio-Processing Systems Market Valued At USD 1,946.7 Mn In 2015, And Is Expected To Reach USD 19,059.3 Mn By 2023, Expanding At A CAGR Of 33.0% From 2016 To 2022
Cell Culture Media And Reagents Market Was Valued At USD3,310.7mn In 2015, And Is Expected To Reach Usd6,872.5mn By 2023, Expanding At A CAGR Of 8.2% From 2016 To 2023
Digital PCR Market Was Valued At USD 196.7 Mn In 2015, And Is Expected To Reach USD 749.4 Mn By 2024, Expanding At A CAGR Of 18.2% From 2016 To 2023
In- Vitro ADME Services Market Was Valued At USD 2,316.5 Mn In 2015, And Is Expected To Reach USD 3,859.1 Mn By 2023, Expanding At A CAGR Of 7.6% From 2016 To 2023
Starter Culture Market Was Valued At USD 814.4mn By Value And 1,107.5 Kilo Ton By Volume In 2015, And Is Expected To Reach USD 1,426.9 Mn By Value And 1,896.1 Kilo Ton By Volume By 2024, Expanding At A CAGR Of 6.1% By Value And 5.8% By Volume From 2016 To 2024
Tropical diseases are the infectious diseases that thrive in the hot and humid climatic conditions, which is suitable for the growth of micro-organisms like parasites, fungi, bacteria and virus.
Cervical Dysplasia Diagnostic Market Was Valued At US$ 437.3 Mn In 2016, And Is Expected To Reach US$ 791.3 Mn By 2025, Expanding At A CAGR Of 6.5% From 2017 To 2025
Next Generation Sequencing Market Was Valued At USD 2.6 Bn In 2015, And Is Expected To Reach USD 20.6 Bn By 2025, Expanding At A CAGR Of 21.5% From 2016 To 2025
Metabolomics Market Was Valued At US$ 621.1 Mn In 2016, And Is Expected To Reach US$ 2,428.1 Mn By 2025, Expanding At A CAGR Of 15.3% From 2017 To 2025
3D Cell Culture Market Was Valued At Us$ 456.8mn In 2016, And Is Expected To Reach US$ 2,734.3 Mn By 2025, Expanding At A CAGR Of 20.0% From 2017 To 2025
Nucleic Acid Testing Market Was Valued At US$ 1.91 Bn In 2016, And Is Expected To Reach US$ 4.5 Bn By 2025, Expanding At A CAGR Of 9.8% From 2017 To 2025
The Market Was Valued At USD 5.3 Bn In 2015, And Is Expected To Reach USD 10.5 Bn By 2025, Expanding At A CAGR Of 7.7% From 2017 To 2025
Blood Gas And Electrolytes Analyzers Market Was Valued At US$ 532.9 Mn In 2016, And Is Expected To Reach US$ 791.7 Mn By 2025, Expanding At A CAGR Of 4.4% From 2017 To 2025
Lab-On-A-Chip Market Was Valued At USD 4.16 Bn In 2015, And Is Expected To Reach USD 9.06 Bn By 2025, Expanding At A CAGR Of 8.9% From 2017 To 2025
Environmental Health & Safety (EHS) Market Was Valued At US$ 3,007.5 Mn In 2016, And Is Expected To Reach US$ ,7323.0 Mn By 2025, Expanding At A CAGR Of 11.8% From 2017 To 2025
HIV/AIDS Diagnostics Market Was Valued At US$ 3,790.2 Mn In 2016, And Is Expected To Reach US$ 8.718.8 Mn By 2025, Expanding At A CAGR Of 9.4% From 2017 To 2025
The Market Was Valued At US$ 3.0 Bn In 2016, And Is Expected To Reach US$ 13.9 Bn By 2025, Expanding At A CAGR Of 18.6% From 2017 To 2025
Live Cell Imaging Market Was Valued At US$ 4,615.0 Mn In 2016, And Is Expected To Reach US$ 9,604.1 Mn By 2025, Expanding At A CAGR Of 8.4% From 2017 To 2025
Influenza Diagnostics Market Was Valued At US$ 541.6 Mn In 2016, And Is Expected To Reach US$ 978.6 Mn By 2025, Expanding At A CAGR Of 6.5% From 2017 To 2025
Cell-Free Protein Expression Market Was Valued At US$ 167.2 Mn In 2016, And Is Expected To Reach US$ 282.3 Mn By 2025, Expanding At A CAGR Of 5.9% From 2017 To 2025
Malaria Diagnostics Market Was Valued At US$ 210.2 Mn In 2016, And Is Expected To Reach US$ 308.2 Mn By 2025, Expanding At A CAGR Of 4.2% From 2017 To 2025
Live Cell Imaging Market Was Valued At US$ 426.1 Mn In 2016, And Is Expected To Reach US$ 886.7 Mn By 2025, Expanding At A CAGR Of 8.4% From 2017 To 2025
Protein Assays Market Was Valued At US$ 984.8 Mn In 2016, And Is Expected To Reach US$ 2,804.6 Mn By 2025, Expanding At A CAGR Of 11.3% From 2017 To 2025
Specialty Enzymes Market Was Valued At US$ 1,826.9 Mn In 2016, And Is Expected To Reach US$ 3,844.4 Mn By 2025, Expanding At A CAGR Of 8.5% From 2017 To 2025
Anatomic Pathologymarket Was Valued At US$ 16,575.62 In 2016, And Is Expected To Reach US$ 27,265.07mn By 2025 Expanding At A CAGR Of 5.5%From 2017to 2025
Tuberculosis Diagnostics Market Was Valued At US$ 2,220.9 Mn In 2016, And Is Expected To Reach US$ 3,326.9 Mn By 2025 Expanding At A CAGR Of 4.5 % From 2017 To 2025
Molecular Diagnostics Market Was Valued At US$ 6,077.9 Mn In 2016, And Is Expected To Reach US$ 12,358.6 Mn By 2025 Expanding At A CAGR Of 7.8 % From 2017 To 2025
Antinuclear Antibody Tests Market Was Valued At US$ 649 Mn In 2016, And Is Expected To Reach US$ 1,588.7 Mn By 2025, Expanding At A CAGR Of 9.8% From 2017 To 2025
Depth Filtration Market Was Valued At US$ 9.04 Bn In 2016, And Is Expected To Reach US$ 16.99 Bn By 2025, Expanding At A CAGR Of 7.2% From 2017 To 2025
Cell Signaling Market Was Valued At US$ 2.48 Bn In 2016, And Is Expected To Reach US$ 4.35 Bn By 2025, Expanding At A CAGR Of 6.4% From 2017 To 2025
High Content Screening Market Was Valued At US$ 1,199.0 Mn In 2016, And Is Expected To Reach US$ 1,988.1 Mn By 2025 Expanding At A CAGR Of 5.82 % From 2017 To 2025
Fluoroscopy Systems Market Was Valued At US$ 2,906.3 Mn In 2016, And Is Expected To Reach US$ 4,619.8 Mn By 2025, Expanding At A CAGR Of 5.1% From 2017 To 2025
Global Cell Culture Protein Surface Coatings Market was estimated to be USD XX Bn in 2017 and was expected to be worth USD XX Bn by 2027. Explore the market Here!
Western Blotting Market Was Valued At US$ 548.9 Mn In 2016, And Is Expected To Reach US$ 872.5 Mn By 2025, Expanding At A CAGR Of 5.1% From 2017 To 2025
Microbiome Sequencing Services Market Was Valued At US$ 498 Mn in 2016, And Is Expected To Reach US$ 2,519.3 Mn by 2025, Expanding At A CAGR of 19.6% From 2017 To 2025
Pharmaceutical Filtration Market Was Valued At US$ 13.4 Bn In 2016, And Is Expected To Reach US$ 33.2 Bn By 2025, Expanding At A CAGR Of 10.57% From 2017 To 2025
Glycomics/ Glycobiology Market Was Valued At US$ 657.3 Mn In 2016, And Is Expected To Reach US$ 1,891.9 Mn By 2025, Expanding At A CAGR Of 12.4% From 2017 To 2025
Immunohistochemistry Market Was Valued At US$ 1,555.2 MN In 2016, And Is Expected To Reach US$ 2,986.4 MN By 2025 Expanding At A CAGR Of 7.19% From 2017 To 2025
Stem Cells Market Was Valued At US$ 5,231.7 Mn In 2016, And Is Expected To Reach US$ 13,731.5 Mn By 2025 Expanding At A CAGR Of 10.50 % From 2017 To 2025
Pyrogen Testing Market Was Valued At US$ 638.7 Mn In 2016, And Is Expected To Reach US$ 1,853.3 Mn By 2025, Expanding At A CAGR Of 12.51% From 2017 To 2025
Sterility Testing Market Was Valued At US$ 548.2 Mn In 2016, And Is Expected To Reach US$ 1,176.9 Mn By 2025 Expanding At A CAGR Of 8.38 % From 2017 To 2025
Endocrine Testing Market Was Valued At US$ 7,359.4 Mn in 2016, And Is Expected To Reach US$ 14,758.6 Mn by 2025, Expanding At A CAGR of 7.9% From 2017 To 2025
High Throughput Process Development Market Was Valued at US$ 10,267.8 Mn in 2016, And Is Expected To Reach US$ 24,600.7 Mn by 2025 Decreasing At A CAGR of 9.55% From 2017 To 2025
Specimen Validity Test (SVT) Reagents Market Was Valued at US$ 832.8 Mn in 2016, and Is Expected To Reach US$ 1,341.9 Mn by 2025, Expanding At A CAGR of 5.4% from 2017 to 2025
Molecular Weight Marker Market Was Valued At US$ 392.1 Mn in 2016, And Is Expected To Reach US$ 1,267.3 Mn by 2025 Expanding At A CAGR of 12.63 % from 2017 to 2025
Ocular Drug Delivery Technologies Market Was Valued At US$ 15,500 Mn In 2016, And Is Expected To Reach US$ 25,697 Mn By 2025, Expanding At A CAGR Of 5.81% From 2017 To 2025
Life Science Microscopy Devices Market Was Valued At US$ 975.4 Mn In 2016, And Is Expected To Reach US$ 1,808.2 Mn By 2025, Expanding At A CAGR Of 7.02% From 2017 To 2025
Recombinant Vaccines Market Is Expanding At A CAGR Of 6.4% From 2017 To 2025
Cell Culture Monitoring Biosensors Market Was Valued At US$ 262.3 Mn In 2016, And Is Expected To Reach US$ 606.3 Mn By 2025, Expanding At A CAGR Of 9.6 % From 2017 To 2025
Sepsis Diagnostics Market Was Valued At US$ 381.8 Bn In 2016, And Is Expected To Reach US$ 764.2 Bn By 2025, Expanding At A CAGR Of 7.6% From 2017 To 2025
Drug Discovery Technologies Market Was Valued At US$ 59.6 Bn In 2016, Expanding At A CAGR Of 12.1% .
Membrane Bioreactor Systems Market Was Valued At US$ 1.54 Bn In 2017, And Is Expected To Reach US$ 5.59 Bn By 2026, Expanding At A CAGR Of 15.46 % From 2018 To 2026
Yersinia is a gram-positive bacteria causing terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children, and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, North Europe, and Scandinavian counties, therefore making these regions the largest markets for Yersinia diagnostics.
In 2021, the global Retinol (Vitamin A) market was valued at USD 6294.8 Million and is projected to reach the value of USD 9341.34 million by 2028.
Stem cells are a class of undifferentiated biological cells of a multicellular organism that have potential to produce indefinite cells of the same type, from which certain type of cells (replication) can be produced by differentiation in the body through early life and growth.
Cell isolation & separation is the process of separating individual living cells from another within a biological sample such as blood or tissue. Cell isolation & separation techniques comprise centrifugation, FACS (fluorescence-activated cell sorting), BACS (buoyancy-activated cell sorting), MACS (magnetic-activated cell sorting), and microfluidics or filtration.
Aptamers are chemically synthesized peptides or oligonucleotide molecules that bind to a specific target nucleic acid, protein, or lipid. Aptamers are used in various fields such as drug delivery, diagnostics, and therapeutics.
Computational biology is an interdisciplinary science that is being persistently advancing through the previous decades by using the power of mathematics and computation.
In 2021, the global Bacteriophage Market was valued at USD 1,172.5 Million and is projected to reach at value of USD 1,441.3 million by 2028.
The circulating tumor cells prognostic technologies market is set to reach US$ 12,443.3 Mn by 2026 from US$ 2,324.7 Mn in 2017 projecting excellent growth at a compounded annual growth rate (CAGR) of 20.8% during the forecast period from 2018 to 2026. As per the latest research findings of World Health Organization (WHO) 2018, cancer is the second largest cause of death globally with an estimation of 9.6 million deaths in 2018.
The global proteomics market held US$ 15.1 Bn in 2017 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2018 to 2026. The market is fueled by the growing importance of sensitive and accurate diagnosis offered by proteomics in personalized medicine.
The global genomics market held US$ 13,122.9 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2018 to 2026. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome.
The global cDNA and oDNA microchips market is growing effectively, was valued at US$ 458.2 Mn in 2017 and expected to reach US$ 1,050.3 Mn by 2026. The global market is growing productively at a CAGR of 9.7% during the forecast period. Incorporation of new technologies in the biological and electronic component of microchips is enhancing the overall growth globally.
The global high throughput screening (HTS) market is growing effectively, valued at US$ 13.2 Bn in 2017 and estimated to reach US$ 24.4 Bn by 2026.
The global forensic technologies market held US$ 3,939.6 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 8.4% during the forecast period from 2018 to 2026.
The growth in demand for sterilization indicators is expected to be driven by growing emphasis on refurbishing and reprocessing of medical devices for tackling the growing healthcare expenses and increasing demand for safe food and drugs.
The global endotoxin testing market is growing significantly, expected to grow at a CAGR of 9.5% from 2018 - 2026. New technological progresses in LAL test is generating major revenue in the global market. Favorable public initiatives in the biotechnology and pharmaceutical sector across various developing countries, and new product launch along with rise in medical device manufacturing will drive the overall market growth.
The nutrigenomics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 portraying excellent growth with a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026.
Microplate instrumentation are important devices used in cell culture and other research.
The metagenomics analysis market is set to reach from US$ 374.6 Mn in 2017 to US$ 1,505.7 Mn in 2026 highlighting rampant growth at a compounded annual growth rate of 16.9% during the forecast period from 2018 to 2026.
The overall growth of animal genetics market is attributed to the growing demand for meat products, need for breeding disease resistant animals due to increasing demand for non-antibiotic produce, increasing outbreaks of diseases in farm animals and so on.
The plasma fractionation market is set to reach from US$ 18,099.5 Mn in 2017 to US$ 33,386.6 Mn by 2026 at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2018 to 2026.
The preterm birth and PROM testing market is set to reach from US$ 996.3 Mn in 2017 to US$ 1,201.2 Mn by 2026 representing slow growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2018 to 2026.
The bone marrow transplantation market is set to reach from US$ 8,356.4 Mn in 2017 to US$ 13,903.1 Mn by 2026 highlighting straightforward growth at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026.
The stem cell alopecia treatment market is set to grow at a compounded annual growth rate (CAGR) of 5.1% during the forecast period from 2018 to 2026.
The recombinant plasma protein therapeutics market is set to grow from US$ 7,788.9 Mn in 2017 to US$ 15,910.5 Mn in 2026 expanding at an annual growth rate of 8.3% during the forecast period from 2018 to 2026.
The histology and cytology market is set to grow from US$ 8,928.1 Mn in 2017 to 27,949.9 Mn by 2026 at a compounded annual growth rate (CAGR) of 13.6% during the forecast period from 2018 to 2026.
The thyroid function test market is set to reach US$ 2,203.7 Mn by 2027 from US$ 1,317.8 Mn in 2018 projecting impressive growth at a compounded annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026.
The donor egg IVF treatment market is set to reach US$ 3,676.8 Mn by 2027 from US$ 1,782.1 Mn in 2018 highlighting moderate growth at a compounded annual growth rate (CAGR) of 8.4% during the forecast period from 2019 to 2027.
In 2021, the global Direct to Consumer Microbiome Analyzing market was valued at USD XX billion and is projected to reach at the value of USD XX billion by 2028.
The cell expansion market is set to reach from US$ 9,743.7 Mn in 2018 to US$ 33,443.2 Mn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027.
The revenue generated by the global Aeroponic Biopharming market in 2021 was over USD 957.11 million and expected to generate revenue worth USD 5,325.47 million in 2028.
Global Marine Algae market has generated revenue of over USD 943.48 million in 2021. It is expected to exhibit CAGR of over 8.07% during the forecast period to reach over USD 1,690.09 million by the end of 2028.
The global gas turbine services market is anticipated to grow at a substantial CAGR of 9.5% in the upcoming years. The global gas turbine services industry is estimated to be worth USD 27.1 billion in 2021 and is expected to be worth USD 46.71 billion by 2028.
Global Biotechnology Market Analysis
The worldwide biotechnology market was forecasted to cross 3,20,000 million dollar mark by end of year 2015 as per the reports provided by global market analysts. Industrial growth is propelled by economic recovery, enhanced research & development funding, biotechnology and government initiatives utilized in medical sciences and agriculture. Emerging economies like India and China are becoming key business market sectors in the fields of industrial biotechnology and agricultural biotechnology.
The economic crises adversely affected the biotechnology industry and brought decline in profits in European Union and USA owing to limited wealth inflows and projects delay or cancellation. The industry has entered the recovery stage with most of the biotechnology outfits producing profits due to new cost effective and money saving measures.
Business funding is on the rise on the flipside of more positive financial conditions, although this funding is focused in a less proportion of bigger outfits. Smaller firms are still struggling to increase research and development funds. The condition is predicted to increase as venture capitalists exercise higher caution in looking for more secured investment choices.
Key Market Sections
The global genetic testing market was predicted to touch 4000 million dollar mark by the end of year 2015. Genetic testing for cancer is predicted to observe one of the highest rates of growth, getting specific interest from private section and scientific population at large. Direct to customer genetic testing is a market section that is expected to take off with most of the new outfits on the industry. Industry shapers includes deCODE and 23andme.
Geographical Market Share
United States of America dominated the worldwide biotechnology market. It was succeeded by European Union which included developed countries like France, Germany, UK and Spain as per the reports provided by global market analysts. Emerging economies such as India and China are predicted to register strong growth in industrial biotechnology as well as in agricultural biotechnology markets owing to rise in levels of disposable incomes and rise in population. Both these Asian nations are playing growingly vital part in the market of biotechnology medicines and drugs on the flipside of relatively low financial investment accompanied by high expertise level.
Industry Overview
As per the global market analysts the growth in the global biotechnology market is predicted to be stimulated by enhanced healthcare services, improved healthcare infrastructure and rising interests of private sector industries in making maximum utilization of information technology to carry out their tasks, work & daily job activities. It is predicted that there merger and acquisitions events are likely to grow in future. It will be stimulated by blockbuster medicine patent expiration and healthcare rules put in place to regulate expenditure. Minor outfits are expected to divest their businesses to bigger outfits or depend upon in-licensing partnerships with more monetarily secured outfits owing to investment restrictions.
Technical modernizations, increase in stringent rules, public awareness and intellectual property rights are few of the aspects that will positively affect the biotechnology segment. Biotechnology uses and applications will continue to rise along with agricultural sector, medical sector, environmental sciences section, health sector and food segment as key end use domain segments .
Business investments in biotechnology sector will constantly strive and aim at making new medical discoveries, make new breakthroughs in methods of medical treatments and use or apply new methods of treatments in field medical research & development. This sector is led by specializations in field of inflammation, oncology and cardiology. Curative categories which includes hormone treatment and treatment for diabetes will receive enhanced focus from companies involved in business of biotechnology in relation and response to growing demand for these treatments from biotechnology market sectors .